Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 8/20 | 0.36 |
| ▸ | CES1 | P23141 | 5/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12393192 | 0.90 | MLYCD (0.42) | MLYCDLMNAMMP1MMP2MMP3 | |
| SCHEMBL12228045 | 0.82 | MLYCD (0.38) | MLYCDLMNAMMP1MMP2MMP3 | |
| SCHEMBL11955740 | 0.82 | MLYCD (0.38) | MLYCDLMNAMMP1MMP2MMP3 | |
| SCHEMBL21235948 | 0.81 | MLYCD (0.39) | MLYCDLMNAMMP1MMP2MMP3 | |
| Choline SCHEMBL15993894 | 0.80 | CYP3A4 (0.46) | MLYCDLMNACHRM2CHRM4CHRM5 | |
| Hydrochloric Acid SCHEMBL1028628 | 0.80 | MLYCD (0.37) | MLYCDLMNAMMP1MMP2MMP3 | |
| SCHEMBL31206489 | 0.80 | CHRM2 (0.39) | MLYCDLMNAMMP1MMP2MMP3 | |
| SCHEMBL18381057 | 0.80 | DPP4 (0.51) | MLYCDCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL26927437 | 0.80 | CHRM2 (0.39) | MLYCDLMNAMMP1MMP2MMP3 | |
| SCHEMBL26927432 | 0.80 | CHRM2 (0.39) | MLYCDLMNAMMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250391920-A1 | ELECTROLYTES FOR LITHIUM METAL BATTERIES | GM GLOBAL TECH OPERATIONS LLC (US) | 2025-12-25 | — | — | US | claimed |
| WO-2025087000-A1 | ELECTROLYTE, BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2025-05-01 | — | — | WO | claimed |
| US-20250112280-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | Westlake University (CN) | 2025-04-03 | — | — | US | claimed |
| WO-2025036379-A1 | ANODE-FREE LITHIUM METAL BATTERY, MANUFACTURING METHOD THEREFOR AND USE THEREOF | 西湖大学 | 2025-02-20 | — | — | WO | claimed |
| WO-2025026128-A1 | NEGATIVE ELECTRODE-FREE LITHIUM METAL BATTERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 西湖大学 | 2025-02-06 | — | — | WO | claimed |
| EP-4471923-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | Westlake University (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-113024390-B | Synthesis method of 3',5' -dichloro-2, 2-trifluoro acetophenone derivative | 台州臻挚生物科技有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-116565325-A | Lithium battery electrolyte with lithium borate salt and trifluoroacetamide compound | 西湖大学 | 2023-08-08 | — | — | CN | claimed |
| WO-2023142739-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | 西湖大学 | 2023-08-03 | — | — | WO | claimed |
| CN-112876345-B | Preparation method of halogenated trifluoroacetyl benzene | 上海康鹏科技股份有限公司 | 2022-11-15 | — | — | CN | claimed |
| CN-110204450-A | A kind of synthetic method of the chloro- 2- trifluoroacetyl aniline hydrochloride hydrate of 4- | 浙江江北药业有限公司 | 2019-09-06 | — | — | CN | claimed |
| US-20180269528-A1 | ELECTROLYTE FOR LTO TYPE LITHIUM ION BATTERIES | SHENZHEN CAPCHEM TECHNOLOGY CO., LTD (CN) | 2018-09-20 | — | — | US | claimed |
| CN-108475814-A | LTO type lithium-ion battery electrolytes | 深圳新宙邦科技股份有限公司 | 2018-08-31 | — | — | CN | claimed |
| US-20170317385-A1 | Electrolyte Compositions For Rechargeable Lithium Ion Batteries | BASF CORPORATION (US) | 2017-11-02 | — | — | US | claimed |
| US-6829257-B2 | Transverse flowing liquid Kerr cell for high average power laser Q-switching and for direct modulation of high power laser beams. | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-12-07 | — | — | US | claimed |
| US-20040146074-A1 | Transverse flowing liquid Kerr Cell for high average power laser Q-switching and for direct modulation of high power laser beams | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-07-29 | — | — | US | claimed |
| US-3941453-A | Birefringent compounds used in Kerr cells | U.S. PHILIPS CORPORATION (US) | 1976-03-02 | — | — | US | claimed |
| WO-2025262036-A1 | METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION | RNASSIST LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| WO-1998041508-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 1998-09-24 | — | — | WO | disclosed |
| WO-1997048683-A1 | SUBSTITUTED BENZAMIDE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS | SMITHKLINE BEECHAM PLC (GB) | 1997-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250391920-A1 | ELECTROLYTES FOR LITHIUM METAL BATTERIES | CACNA1F, LPO, LETM1 | MLYCD 243/4885LMNA 1062/4885MMP1 1448/4885 |
| US-20250112280-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | HCN2, SLC9A5, SLC9B2 | MLYCD 1271/4885LMNA 1225/4885MMP1 2977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.